Sanofi (LTS:0O59) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0O59 Sanofi SA LTS:0O59
77 GF Score
Price €77.37
GF Value €106.87
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sanofi Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

LTS:0O59
77GF Score
Sanofi SA LTS:0O59
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sanofi (LTS:0O59) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of €77.37 is trading 27.6% below its estimated GF Value™ of €106.87. GuruFocus considers Sanofi to be Modestly Undervalued.

Key valuation signals for LTS:0O59:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €106.87 vs. price of €77.37 (27.6% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the LTS:0O59 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
77GF Score

Get the complete analysis for LTS:0O59

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€77.37
Price
€106.87
GF Value